Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder

Objective: Current extended-release (ER) formulations of psychostimulants used for treatment of attention-deficit/hyperactivity disorder (ADHD) provide an extended duration of ADHD symptom control; however, the onset of efficacy can be protracted and variable, leaving the early morning untreated. Th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Child Adolesc Psychopharmacol
Autors principals: Childress, Ann, Mehrotra, Shailly, Gobburu, Jogarao, McLean, Angus, DeSousa, Norberto J., Incledon, Bev
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5771548/
https://ncbi.nlm.nih.gov/pubmed/29039979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2017.0044
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars